Literatur
- 1
Bellomo R, Ronco C, Kellum J A, Mehta R L, Palevsky P.
Acute renal failure – definition, outcome measures,
animal models, fluid therapy and information technology needs: the
Second International Consensus Conference of the Acute Dialysis
Quality Initiative (ADQI) Group.
Crit Care.
2004;
8
R204-212
- 2
Fellstrom B C, Jardine A G, Schmieder R E. et al .
Rosuvastatin and cardiovascular
events in patients undergoing hemodialysis.
N Engl J Med.
2009;
360
1395-1407
- 3
Glassock R J, Winearls C.
Screening for CKD with
eGFR: doubts and dangers.
Clin J Am Soc Nephrol.
2008;
3
1563-1568
- 4
Mann J F, Schmieder R E, McQueen M. et al .
Renal outcomes with telmisartan, ramipril, or
both, in people at high vascular risk (the ONTARGET study): a multicentre,
randomised, double-blind, controlled trial.
Lancet.
2008;
372
547-553
- 5
Parving H H, Persson F, Lewis J B, Lewis E J, Hollenberg N K.
Aliskiren combined with losartan in type
2 diabetes and nephropathy.
N Engl J Med.
2008;
358
2433-2446
- 6
Ricci Z, Cruz D, Ronco C.
The
RIFLE criteria and mortality in acute kidney injury: A systematic
review.
Kidney Int.
2008;
73
538-546
- 7
Wenzel R R, Littke T, Kuranoff S. et al .
Avosentan reduces albumin excretion in
diabetics with macroalbuminuria.
J Am Soc Nephrol.
2009;
20
655-664
Prof. Dr. Walter Zidek
Medizinische Klinik IV, Charité Campus
Benjamin Franklin, Universitätsmedizin
Berlin
Hindenburgdamm 30
12200 Berlin
Phone: 030/8445-2441
Email: walter.zidek@charite.de
